Bone Cement Glue Market Size 2026-2030
The bone cement glue market size is valued to increase by USD 741.6 million, at a CAGR of 6.9% from 2025 to 2030. Growing prevalence of orthopedic disorders due to rise in trauma cases will drive the bone cement glue market.
Major Market Trends & Insights
- North America dominated the market and accounted for a 46.9% growth during the forecast period.
- By Type - Bone cement segment was valued at USD 1.69 billion in 2024
- By End-user - Hospitals segment accounted for the largest market revenue share in 2024
Market Size & Forecast
- Market Opportunities: USD 1.18 billion
- Market Future Opportunities: USD 741.6 million
- CAGR from 2025 to 2030 : 6.9%
Market Summary
- The bone cement glue market is shaped by the dual forces of a growing elderly population requiring orthopedic interventions and the continuous pursuit of advanced biomaterials to enhance surgical outcomes. Demand is fundamentally linked to the high volume of arthroplasty procedures, where materials offering superior implant fixation and biocompatibility are critical.
- Key industry drivers include the rising incidence of trauma-related injuries and degenerative joint diseases. However, the sector faces considerable challenges related to the exothermic curing temperature of traditional cements, which can risk thermal necrosis, and the persistent threat of periprosthetic joint infection (PJI).
- For hospital systems, this creates a complex procurement scenario; they must evaluate new composite bone cement and antibiotic-loaded bone cement (ALBC) options, balancing initial acquisition costs against the long-term financial and clinical impact of revision surgeries. A focus on improving the bone-cement interface and developing biodegradable bone adhesives reflects a strategic shift toward regenerative medicine.
- The stringent regulatory approval process, mandating extensive clinical efficacy data, acts as a significant barrier for new entrants, reinforcing the position of established players with robust good manufacturing practices (GMP) and post-market surveillance programs.
What will be the Size of the Bone Cement Glue Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Request Free Sample
How is the Bone Cement Glue Market Segmented?
The bone cement glue industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2026-2030, as well as historical data from 2020-2024 for the following segments.
- Type
- Bone cement
- Bone glue
- End-user
- Hospitals
- Clinics
- Ambulatory surgery centers
- Application
- Arthroplasty
- Trauma surgery
- Kyphoplasty
- Others
- Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Asia
- Rest of World (ROW)
- North America
By Type Insights
The bone cement segment is estimated to witness significant growth during the forecast period.
The bone cement glue market is segmented by material science, with polymethylmethacrylate (PMMA) forming the backbone of the industry due to its proven mechanical properties and established use in implant fixation.
However, the landscape is evolving with the growing adoption of calcium phosphate cement (CPC), valued for its bioactive properties and osteoconductive potential. Innovations in glass polyalkenoate cement (GPC) are also gaining traction for applications requiring direct chemical adhesion to bone.
Demand is further shaped by the need for specific rheological qualities for different surgical needs, from high viscosity cement for immediate load-bearing to low viscosity cement for complex fracture filling.
North America’s market accounts for 46.9% of the incremental growth opportunity, steering development toward enhanced biocompatibility and biomaterial integration to reduce aseptic loosening and improve long-term outcomes in joint reconstruction.
The Bone cement segment was valued at USD 1.69 billion in 2024 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 46.9% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Bone Cement Glue Market Demand is Rising in North America Request Free Sample
Geographically, the market is led by North America, which is projected to grow at a rate of 7.6% and accounts for 46.9% of the total incremental growth opportunity.
This dominance is sustained by advanced healthcare infrastructure, high procedural volumes in orthopedic trauma surgery, and rapid adoption of innovations in drug-eluting capabilities. Europe follows as a mature market with significant R&D in biomaterial integration.
Meanwhile, Asia is emerging as a high-growth region, expanding at 6.7%, driven by improving healthcare access and rising demand for spinal fusion surgery and arthroplasty fixation techniques.
The development of tissue engineering scaffolds and advancements in cranioplasty applications are becoming globally influential, with regional manufacturing hubs adapting to meet stringent ISO 13485 compliance and diverse regulatory standards worldwide.
Market Dynamics
Our researchers analyzed the data with 2025 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
- Improving long-term patient outcomes is the central objective driving innovation in the bone cement glue market. In primary procedures like bone cement for total hip replacement and bone cement for total knee replacement, the focus is on achieving durable fixation to lower revision rates with advanced cements.
- The development of high fatigue strength bone cement for longevity directly addresses this, aiming to prevent mechanical failure over time. For vertebral compression fractures, minimally invasive vertebroplasty bone cement and injectable bone cement for kyphoplasty offer significant benefits.
- Success in these procedures hinges on material properties, leading to research into optimizing rheology for cement interdigitation and using radiopaque cement for guided spinal procedures. A critical area of development involves managing exothermic reaction in PMMA cements to prevent thermal necrosis, a significant clinical risk.
- This has spurred interest in alternatives like calcium phosphate cement for bone regeneration and formulations incorporating bioactive glass in bone cement. The use of antibiotic loaded bone cement for arthroplasty is now standard for infection prophylaxis. Future growth areas include bone glue applications in sports medicine and biodegradable adhesives for pediatric orthopedics.
- Adopting advanced mixing systems can reduce material porosity, a factor linked to a decrease in aseptic loosening cases by up to 10%, directly impacting hospital quality metrics.
What are the key market drivers leading to the rise in the adoption of Bone Cement Glue Industry?
- A primary market driver is the growing prevalence of orthopedic disorders, stemming from a global rise in trauma cases and an aging population.
- The market's growth is fundamentally driven by demographic and epidemiological factors. An aging global population and rising rates of obesity are increasing the prevalence of degenerative conditions that necessitate joint reconstruction and arthroplasty fixation techniques.
- In parallel, the high incidence of orthopedic trauma surgery continues to fuel demand for reliable fixation materials.
- In certain developed nations, trauma is a leading cause of death for younger populations, with nearly 79,000 fatalities annually, while over 12,500 new spinal injuries occur yearly, creating a sustained need for vertebral augmentation and spinal fusion surgery.
- This environment propels the use of established PMMA monomer-based products and spurs R&D into advanced bone void fillers with superior compressive strength and osteoconductive bone graft properties to address a wide spectrum of clinical scenarios.
What are the market trends shaping the Bone Cement Glue Industry?
- The growing adoption of minimally invasive techniques is emerging as a significant market trend, influencing procedural choices and product requirements.
- A pivotal trend shaping the market is the accelerated adoption of minimally invasive techniques, which fundamentally alters procedural requirements and material selection. The rising popularity of kyphoplasty procedures and minimally invasive vertebroplasty for treating spinal fractures is a primary catalyst, demanding cements with specific setting time and dough time characteristics.
- This shift improves patient outcomes, with data showing that such techniques can reduce hospital stays by up to 40% and accelerate recovery times by nearly 30% compared to traditional open surgeries. Consequently, innovation is focused on developing advanced cement delivery systems and steerable needle technology to enhance precision.
- This trend is coupled with a push toward materials with a lower exothermic reaction to ensure patient safety in confined surgical sites, driving R&D in both acrylic bone cement alternatives and nanoparticle addition to existing formulations.
What challenges does the Bone Cement Glue Industry face during its growth?
- The enforcement of strict regulatory standards and complex compliance requirements for bone cement and glue products poses a significant challenge to market growth.
- Significant challenges in the market revolve around stringent regulatory pathways and the inherent limitations of existing biomaterials. The complex regulatory approval process, governed by bodies like the FDA and under frameworks such as the EU MDR, imposes high barriers to entry.
- Navigating these requirements can increase compliance-related overhead by 25-30% and delay time-to-market by as much as 18 months for novel products, demanding robust clinical efficacy data and post-market surveillance. On the materials science front, challenges include managing PMMA monomer toxicity, preventing the stress-shielding effect, and combating antibiotic resistance concerns associated with long-term implantable devices.
- These issues compel manufacturers to invest heavily in R&D to improve implant survivorship rates and demonstrate adherence to good manufacturing practices (GMP), creating a competitive landscape where technical and regulatory expertise are paramount.
Exclusive Technavio Analysis on Customer Landscape
The bone cement glue market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the bone cement glue market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape of Bone Cement Glue Industry
Competitive Landscape
Companies are implementing various strategies, such as strategic alliances, bone cement glue market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
aap Implantate AG - Offers a range of bone cement solutions, from osteoconductive formulations to antibiotic-loaded variants, designed for orthopedic fixation, reconstruction, and void filling applications.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- aap Implantate AG
- Arthrex Inc.
- Cardinal Health Inc.
- Enovis Corp.
- Exactech Inc.
- G21 Srl
- Globus Medical Inc.
- Heraeus Holding GmbH
- Johnson and Johnson Services
- Medtronic Plc
- Orthofix Medical Inc.
- Smith and Nephew plc
- Stryker Corp.
- Tecres Spa
- Teknimed
- Zimmer Biomet Holdings Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Bone cement glue market
- In August 2024, Innovate Orthopedics received US Food and Drug Administration (FDA) 510(k) clearance for its new-generation composite bone cement, featuring enhanced fatigue strength and a lower curing temperature.
- In November 2024, BioFix Solutions announced a strategic partnership with a leading surgical robotics company to develop and commercialize an automated cement delivery system for minimally invasive spinal surgeries.
- In February 2025, Zimmer Biomet Holdings Inc. launched its Tekcem 1G and Tekcem 3G antibiotic bone cements in India, expanding its portfolio of infection-preventing solutions in the region.
- In April 2025, OrthoCorp, a major orthopedic device manufacturer, completed the acquisition of a biomaterials startup for approximately USD 150 million, gaining access to novel biodegradable bone adhesives for its regenerative medicine division.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Bone Cement Glue Market insights. See full methodology.
| Market Scope | |
|---|---|
| Page number | 285 |
| Base year | 2025 |
| Historic period | 2020-2024 |
| Forecast period | 2026-2030 |
| Growth momentum & CAGR | Accelerate at a CAGR of 6.9% |
| Market growth 2026-2030 | USD 741.6 million |
| Market structure | Fragmented |
| YoY growth 2025-2026(%) | 6.2% |
| Key countries | US, Canada, Mexico, Germany, UK, France, Italy, Spain, The Netherlands, China, India, Japan, South Korea, Indonesia, Thailand, Brazil, Saudi Arabia, UAE, Turkey, Argentina, Colombia, South Africa and Israel |
| Competitive landscape | Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Research Analyst Overview
- From a strategic perspective, the bone cement glue market presents a clear tension between legacy materials and next-generation innovation. Boardroom decisions increasingly center on allocating R&D capital toward novel composite bone cement and bioactive properties found in calcium phosphate cement (CPC), which promise enhanced osteointegration and regenerative potential.
- This contrasts with the established dominance of polymethylmethacrylate (PMMA), a material valued for its predictable mechanical properties and extensive clinical history. The development of antibiotic-loaded bone cement (ALBC) has been a critical enhancement, addressing the significant clinical challenge of periprosthetic joint infection (PJI).
- However, true disruption lies in technologies that mitigate risks like thermal necrosis from the exothermic curing temperature and improve fatigue strength.
- The fact that primary joint replacements outpace revision surgeries by a ratio of more than 25 to 1 underscores the immense strategic value placed on the durability and reliability of initial implant fixation, pushing manufacturers to refine everything from cement mantle consistency to drug-eluting capabilities and overall biocompatibility.
What are the Key Data Covered in this Bone Cement Glue Market Research and Growth Report?
-
What is the expected growth of the Bone Cement Glue Market between 2026 and 2030?
-
USD 741.6 million, at a CAGR of 6.9%
-
-
What segmentation does the market report cover?
-
The report is segmented by Type (Bone cement, and Bone glue), End-user (Hospitals, Clinics, and Ambulatory surgery centers), Application (Arthroplasty, Trauma surgery, Kyphoplasty, and Others) and Geography (North America, Europe, Asia, Rest of World (ROW))
-
-
Which regions are analyzed in the report?
-
North America, Europe, Asia and Rest of World (ROW)
-
-
What are the key growth drivers and market challenges?
-
Growing prevalence of orthopedic disorders due to rise in trauma cases, Strict regulatory standards and requirements regarding bone cement and glue
-
-
Who are the major players in the Bone Cement Glue Market?
-
aap Implantate AG, Arthrex Inc., Cardinal Health Inc., Enovis Corp., Exactech Inc., G21 Srl, Globus Medical Inc., Heraeus Holding GmbH, Johnson and Johnson Services, Medtronic Plc, Orthofix Medical Inc., Smith and Nephew plc, Stryker Corp., Tecres Spa, Teknimed and Zimmer Biomet Holdings Inc.
-
Market Research Insights
- The market's momentum is driven by powerful demographic and clinical dynamics. In key markets, the volume of procedures like total knee arthroplasty is projected to increase by over 140%, fueling demand for reliable fixation solutions in joint reconstruction and revision arthroplasty. Concurrently, the adoption of minimally invasive vertebroplasty and kyphoplasty procedures is expanding the use case for specialized injectable cements.
- From a procurement standpoint, the impact of material costs on hospital budgets is high, creating a preference for comprehensive bone cement mixing systems and delivery technologies that improve procedural efficiency by over 15%.
- This focus on value drives innovation in areas like pre-colored cement visualization and steerable needle technology, which enhance surgical precision and reduce operating time, thereby aligning clinical needs with economic pressures.
We can help! Our analysts can customize this bone cement glue market research report to meet your requirements.